DRW Holdings »

BioCryst Pharmaceuticals shares owned by DRW Holdings

Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by DRW Holdings from 13F filings

Historical chart of DRW Holdings investment in BioCryst Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including BioCryst Pharmaceuticals held by DRW Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioCryst Pharmaceuticals by DRW Holdings

Quarter filed Position value Share count Share price at filing
2025-09-30 $788k 105k 7.48
2025-06-30 $96k 11k 8.96
2024-06-30 $74k 12k 6.18

More positions owned by DRW Holdings

iShares Russell 2000 Index Call Option (IWM)
Ishares Bitcoin Trust Etf Common Call Option (IBIT)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Vaneck Semiconductor Etf Common Put Option (SMH)
Ishares Tr Ishares Common Put Option (SOXX)
Tesla Motors Call Option (TSLA)
Palo Alto Networks Call Option (PANW)
Circle Internet Group Com Cl A Call Option (CRCL)
Micron Technology Common Call Option (MU)
Ishares Ethereum Tr SHS Call Option (ETHA)
NVIDIA Corporation Call Option (NVDA)
Vestas Call Option (VWSYF)
Crowdstrike Hldgs Cl A Call Option (CRWD)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Apple Call Option (AAPL)

View all positions for DRW Holdings

Top funds holding BioCryst Pharmaceuticals

Vanguard Group
BlackRock
Deerfield Management Company
State Street Corporation
Kynam Capital Management
UBS Group
Alkeon Capital Management
Morgan Stanley
Arrowstreet Capital, Limited Partnership
Geode Capital Management
Two Sigma Investments
Two Sigma Advisers
Hood River Capital Management
Nuveen
Assenagon Asset Management

View all funds holding BioCryst Pharmaceuticals